• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和成人免疫性血小板减少症的前瞻性对比观察研究:2 年随访。

A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up.

机构信息

Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland.

Department of Hematology, University Hospital Basel, Basel, Switzerland.

出版信息

Am J Hematol. 2018 Jun;93(6):751-759. doi: 10.1002/ajh.25086. Epub 2018 Mar 30.

DOI:10.1002/ajh.25086
PMID:29516627
Abstract

Comparative clinical studies of children and adults with immune thrombocytopenia (ITP) are poorly covered in the literature. However, the accepted classification of ITP-childhood ITP and adult ITP-results in considerable differences in treatment protocols and practice guidelines. The analysis of the Pediatric and Adult Registry on Chronic ITP (PARC-ITP) of patients at first presentation demonstrated fewer differences in clinical and laboratory findings at initial diagnosis between children and adults than expected. The present report of 2-year follow-up data supports the hypothesis that there are common aspects of childhood and adult ITP. Data of 3360 children and 420 adults were collected during the time of 2004 until 2015 at initial diagnosis. Follow-up information was available for 51% and 33% of children and 66% and 49% of adults at 12- and 24-months, respectively. Similarities were found in unexpected areas of ITP, such as the rate of late remission at 12 and 24 months, reported bleeding sites, platelet count in bleeders, and the frequency of treated patients with persistent or chronic ITP. Differences were confirmed for the overall rate of remission and treatment modalities. Unexpected differences were found in the percentage of nonbleeders, with more adults in the nonbleeder group. More studies are needed to investigate different age groups with the aim to optimize their management.

摘要

儿童和成人免疫性血小板减少症 (ITP) 的临床对比研究在文献中报道较少。然而,公认的 ITP 分类——儿童 ITP 和成人 ITP——导致治疗方案和实践指南存在显著差异。对慢性 ITP 儿科和成人登记 (PARC-ITP) 患者首次就诊的分析表明,与预期相比,儿童和成人在初始诊断时的临床和实验室发现差异较小。本报告中对 2 年随访数据的分析支持了以下假设,即儿童和成人 ITP 存在共同的方面。2004 年至 2015 年期间,共收集了 3360 名儿童和 420 名成人的初始诊断数据。分别有 51%和 33%的儿童和 66%和 49%的成人在 12 个月和 24 个月时可获得随访信息。在 ITP 的意外领域中发现了相似之处,例如 12 个月和 24 个月时的晚期缓解率、报告的出血部位、出血患者的血小板计数以及持续性或慢性 ITP 的治疗患者的频率。在总体缓解率和治疗方式方面存在差异。在非出血者的百分比方面也发现了意外的差异,非出血者中成年人的比例更高。需要进行更多的研究来调查不同年龄组,以优化他们的管理。

相似文献

1
A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up.儿童和成人免疫性血小板减少症的前瞻性对比观察研究:2 年随访。
Am J Hematol. 2018 Jun;93(6):751-759. doi: 10.1002/ajh.25086. Epub 2018 Mar 30.
2
Pediatric ITP: is it different from adult ITP?儿童 ITP:与成人 ITP 有何不同?
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):405-411. doi: 10.1182/asheducation-2018.1.405.
3
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.新诊断免疫性血小板减少症患儿缓解的预测因素:来自洲际合作免疫性血小板减少症研究组登记处II参与者的数据。
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26736. Epub 2017 Aug 9.
4
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).儿童特发性血小板减少性紫癜:来自洲际儿童特发性血小板减少性紫癜研究组(ICIS)前瞻性登记I的12个月随访数据。
Pediatr Blood Cancer. 2006 Mar;46(3):351-6. doi: 10.1002/pbc.20453.
5
Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.新诊断为原发性免疫性血小板减少症的青少年和年轻成人。
Haematologica. 2023 Oct 1;108(10):2783-2793. doi: 10.3324/haematol.2022.282524.
6
Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).持续性和慢性免疫性血小板减少症患儿的出血表现和处理:来自国际免疫性血小板减少症协作研究组(ICIS)的数据。
Blood. 2013 May 30;121(22):4457-62. doi: 10.1182/blood-2012-12-466375. Epub 2013 Apr 2.
7
[Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].[自身免疫性血小板减少性紫癜的管理:来自区域网络RHémaP的147名儿童的前瞻性研究]
Arch Pediatr. 2008 Sep;15(9):1398-406. doi: 10.1016/j.arcped.2008.06.007. Epub 2008 Aug 3.
8
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.特发性血小板减少性紫癜:阿拉巴马儿童医院的一项为期10年的自然史研究。
Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802.
9
High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.儿童慢性免疫性血小板减少症的高缓解率:20年随访结果
Yonsei Med J. 2016 Jan;57(1):127-31. doi: 10.3349/ymj.2016.57.1.127.
10
Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.成人和儿童慢性持续性免疫性血小板减少症(ITP)脾切除术后的长期结局:ITP的脾切除术
Ann Hematol. 2016 Sep;95(9):1429-34. doi: 10.1007/s00277-016-2738-3. Epub 2016 Jul 2.

引用本文的文献

1
Clinical and Laboratory Characteristics of Children with Chronic Idiopathic Thrombocytopenic Purpura.慢性特发性血小板减少性紫癜患儿的临床及实验室特征
Diagnostics (Basel). 2025 May 12;15(10):1217. doi: 10.3390/diagnostics15101217.
2
Immune thrombocytopenia in adolescents and young adults.青少年和青年的免疫性血小板减少症
Front Med (Lausanne). 2025 Mar 26;12:1553936. doi: 10.3389/fmed.2025.1553936. eCollection 2025.
3
Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report.
巴瑞替尼治疗儿童慢性免疫性血小板减少症及相关自身免疫性疾病:一例报告
Front Pediatr. 2024 Dec 24;12:1516039. doi: 10.3389/fped.2024.1516039. eCollection 2024.
4
Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study.免疫性血小板减少症患者逐渐减量并停用 fostamatinib 后的血小板反应:Fostasur 研究的延续
J Clin Med. 2024 Oct 22;13(21):6294. doi: 10.3390/jcm13216294.
5
Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.慢性原发性免疫性血小板减少症青少年及青年患者长期随访中的持续缓解情况
Blood Adv. 2024 Dec 24;8(24):6183-6194. doi: 10.1182/bloodadvances.2024014381.
6
Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag.在艾曲泊帕时代之前30多年来小儿慢性免疫性血小板减少症的经验
Children (Basel). 2024 Aug 28;11(9):1051. doi: 10.3390/children11091051.
7
Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis.低剂量静脉注射免疫球蛋白治疗新诊断免疫性血小板减少症儿童:系统评价和荟萃分析方案。
BMJ Open. 2023 Jun 29;13(6):e071644. doi: 10.1136/bmjopen-2023-071644.
8
IL-4Rα (rs1801275) A>G polymorphism in Egyptian immune thrombocytopenia (ITP) patients: a single center experience.埃及免疫性血小板减少症(ITP)患者中白细胞介素-4受体α(rs1801275)A>G多态性:单中心经验
Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):352-359. doi: 10.1016/j.htct.2023.03.022. Epub 2023 May 8.
9
Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.新诊断为原发性免疫性血小板减少症的青少年和年轻成人。
Haematologica. 2023 Oct 1;108(10):2783-2793. doi: 10.3324/haematol.2022.282524.
10
[Maintenance of efficacy and its predictors after discontinuation of eltrombopag in adults with primary immune thrombocytopenia].[原发性免疫性血小板减少症成人患者停用艾曲泊帕后疗效的维持及其预测因素]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):32-37. doi: 10.3760/cma.j.issn.0253-2727.2023.01.006.